Position in DNLI
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$72,652,467
-$11,872,492 QoQ
Shares Held
2,824,746
-44.8% QoQ
Ownership
1.77%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 290 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. DNLI ranks #26 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,971,681 | $1,476,123,103 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,172,808 | $731,292,700 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,271,813 | $683,883,867 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
8,207,954 | $469,659,127 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,157,479 | $404,052,667 | |
| 6 | INSM |
INSMED Inc
|
3,377,641 | $360,124,083 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,896,536 | $317,606,649 | |
| 8 | RPRX |
Royalty Pharma plc
|
5,336,084 | $299,194,229 |
All Filings in DNLI
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $72,652,467 | 2,824,746 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $84,524,959 | 5,119,622 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $55,223,944 | 3,947,387 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $41,432,203 | 3,047,606 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $21,717,091 | 1,065,608 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $11,580,311 | 397,539 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $19,131,910 | 823,941 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $25,357,918 | 1,235,766 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $24,735,783 | 1,152,646 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $16,584,291 | 803,892 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $17,125,656 | 580,334 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $22,335,897 | 969,440 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $28,483,168 | 1,024,206 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $28,953,068 | 943,404 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $24,480,138 | 831,809 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $27,217,846 | 846,063 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $37,736,461 | 846,109 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $43,051,810 | 853,356 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $58,200,911 | 741,980 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $34,132,438 | 597,766 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $71,734,493 | 856,429 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $32,475,344 | 906,373 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $22,549,760 | 932,579 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $16,608,900 | 948,538 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||